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Summary
The regulated oscillation of protein expression is an
essential mechanism of cell cycle control. The SCF
class of E3 ubiquitin ligases is involved in this pro-
cess by targeting cell cycle regulatory proteins for
degradation by the proteasome, with the F-box sub-
unit of the SCF specifically recruiting a given sub-
strate to the SCF core. Here we identify NIPA (nuclear
interaction partner of ALK) as a human F-box-contain-
ing protein that defines an SCF-type E3 ligase
(SCFNIPA) controlling mitotic entry. Assembly of this
SCF complex is regulated by cell-cycle-dependent
phosphorylation of NIPA, which restricts substrate
ubiquitination activity to interphase. We show nuclear
cyclin B1 to be a substrate of SCFNIPA. Inactivation of
NIPA by RNAi results in nuclear accumulation of
cyclin B1 in interphase, activation of cyclin B1-Cdk1
kinase activity, and premature mitotic entry. Thus,
SCFNIPA-based ubiquitination may regulate S-phase
completion and mitotic entry in the mammalian cell
cycle.
Introduction
Cell cycle-specific proteolysis involves the addition of
ubiquitin molecules along a cascade of E1, E2, and E3
enzymes to target proteins, thus marking them for deg-
radation by the proteasome (Hochstrasser, 1996). The
E3 ubiquitin-protein ligases are critical in these ubiquiti-
nation reactions, as they allow the transfer of activated
ubiquitin from E2 enzymes to the target protein and me-
diate the specificity of substrate recognition (Weiss-
man, 2001). Two types of E3 ligase complexes are
prominent in controlling the abundance of cell cycle
regulatory proteins: the APC and the SCF. The APC
(anaphase-promoting complex) is a multisubunit com-
plex that targets substrates for degradation only during
mitosis and G1 and is responsible for targeting mitotic
cyclins and proteins involved in sister chromatid cohe-
sion and spindle function (Zachariae and Nasmyth,
1999). More recently, the SCF class of E3 ubiquitin li-*Correspondence: justus.duyster@lrz.tum.de
3 Present address: Department of Pediatrics, Tokyo Dental College,
Ichikawa General Hospital, Chiba, Japan.gases has been identified (Jackson and Eldridge, 2002).
These complexes consist of four subunits: Skp1, Cul1,
Roc1, and an interchangeable F-box protein (Fbp), the
latter of which determines substrate specificity (Bai et
al., 1996; Skowyra et al., 1997). Members of the F-box
protein family have a bipartite structure: a shared
N-terminal F-box motif that links F-box proteins to
Skp1 and the SCF core complex and a C-terminal diver-
gent protein-protein interaction motif, which selectively
binds the cognate substrate(s) (Cardozo and Pagano,
2004). The core components of the SCF (Skp1, Cul1,
Roc1) are abundant throughout the cell cycle, and ubiq-
uitin ligase activity is thought to be regulated at the
level of substrate availability and substrate phosphory-
lation (Jackson and Eldridge, 2002). Thus far, it has re-
mained mostly elusive whether the F-box component
contributes to the timing process of cell-cycle-depen-
dent ubiquitination, although some data suggest that
regulated abundance of Fbps may be involved (Galan
and Peter, 1999; Zhou and Howley, 1998). Only recently,
evidence of crosstalk between the APC and SCF has
emerged that demonstrates a link between the two E3
ligases in terms of their interdependent regulation of
enzymatic activity and cooperation in substrate ubiq-
uitination (Ayad et al., 2003; Bashir et al., 2004; Wei et
al., 2004). In this regard, a dual mode of degradation
has been described for the Cdc25A phosphatase (Bus-
ino et al., 2003). While most cell-cycle-related functions
of SCF complexes have been related to the G1/S transi-
tion, other cell cycle transitions also require SCF-medi-
ated protein degradation (Carrano et al., 1999; Naka-
yama et al., 2004; Strohmaier et al., 2001). Genetic
experiments in yeast have shown that cells harboring
certain mutants of Skp1 arrest as large, budded single-
nucleus-containing cells with a G2 DNA content, and
several studies suggest a role for SCF-dependent pro-
teolysis in Xenopus and mammalian cells in G2 phase
and mitosis (Ayad et al., 2003; Bai et al., 1996; Guarda-
vaccaro et al., 2003; Michael and Newport, 1998).
Entry into mitosis is triggered by the activated cyclin
B1/Cdk1 complex (also known as M-phase-promoting
factor or MPF), the activity of which must be exquisitely
controlled during the cell cycle (Minshull et al., 1989).
In the course of mitosis, cyclin B1 is targeted for ubiq-
uitination by the APC in anaphase to allow for subse-
quent mitotic exit (King et al., 1995; Zachariae and
Nasmyth, 1999). Tight control of MPF activity is particu-
larly important during interphase, since untimely activa-
tion can trigger premature mitotic entry, thereby com-
promising the fidelity of genome replication. Nuclear
abundance of cyclin B1 is a major determinant of MPF
activity, thus necessitating regulatory means for timing
of the subcellular localization of this cyclin. The pre-
dominant cytoplasmic localization of cyclin B1, which
is reversed only upon phosphorylation of the CRS (cy-
toplasmic retention signal) region, and the switchlike
upregulation of Cdk1-cyclin B1 activity in response to
an increase in cyclin B1 concentration have emerged
as potentially relevant restraints (Pines and Hunter, 1991;
Yang et al., 1998). In addition, the impact of nuclear
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46cyclin B1 has recently broadened with the identification f
1of its S-phase-promoting potential (Moore et al., 2003).
Therefore, identification of the mechanisms that control m
wcyclin B1 expression and function spatially and tempo-
rally are crucial for understanding DNA replication and d
Wthe timing of mitotic entry.
Recently, we identified NIPA (nuclear interaction part- c
tner of ALK) as a protein of widespread expression and
exclusive nuclear subcellular location in a screen to p
aidentify phosphotyrosine-dependent interaction part-
ners of the activated anaplastic lymphoma kinase (ALK) (
receptor tyrosine kinase. Constitutively active onco-
genic fusion forms of ALK contribute to the devel- N
opment of certain human lymphomas and sarcomas t
(Duyster et al., 2001; Ouyang et al., 2003). Here we W
characterize NIPA as a human F-box protein that de- f
fines an SCF-type ubiquitin E3 ligase, the formation of c
which is regulated by cell-cycle-dependent phosphory- p
lation of NIPA. This phosphorylation event commences e
in G2 phase, results in dissociation of NIPA from the a
SCF core, and proves to be critical for proper G2/M S
transition. We identify cyclin B1 as a substrate of the s
SCFNIPA, which is accordingly targeted for ubiquitination
during interphase only. In addition to the well-known a
APC-mediated degradation of cyclin B1 in mitosis, our t
data suggest an SCF-based ubiquitination process in- r
volving cyclin B1 in interphase, thereby providing a mech- p
anism to inhibit premature nuclear accumulation of t
cyclin B1 during the mammalian cell cycle. a
t
aResults
t
bCell-Cycle-Dependent Expression
band Phosphorylation of NIPA
sWe initially isolated NIPA as a human nuclear protein in
a screen for activated ALK binding proteins (Ouyang et
al., 2003). In an effort to determine whether NIPA plays N
ta role in cell cycle control, we assayed for modifications
of the protein throughout the mammalian cell cycle. S
tNIPA expression was minimal in growth-arrested cells
(G0/1) and became abundant in S and G2/M phases (Fig- w
kure 1A). Moreover, the apparent molecular mass of
NIPA was increased in G2/M cells (Figure 1A). This mo- a
wbility shift was sensitive to phosphatase treatment and
thus most likely due to phosphorylation (Figure 1B). To f
passess NIPA levels and phosphorylation in the ongoing
cell cycle, we released synchronized cells from either S a
fphase or the G2/M boundary and assayed for expres-
sion and phosphorylation of the protein. As depicted f
uin Figure 1C, NIPA phosphorylation increased as cells
approached G2/M. Analysis of the cell cycle phase tran-
(sition times of the NIH 3T3 cells used suggested an
onset of NIPA phosphorylation in G2 phase, with a peak s
sat the G2/M boundary. After the G2/M transition, NIPA
phosphorylation and expression levels declined precip- a
witously upon reentry into G1 (Figure 1C, right panel).
Using tryptic phosphopeptide analysis combined with S
(the engineering of mutations of candidate phosphoryla-
tion sites, we determined that serine 354 is a major w
cphosphorylation site during the course of cell-cycle-
dependent phosphorylation of NIPA (Figure 1D). a
sWe next generated polyclonal murine NIPA antibod-
ies to demonstrate that these cell cycle effects are valid aor the endogenous NIPA protein. As shown in Figure
E, the NIPA antibody detects a protein of the expected
olecular mass (66 kDa) in HeLa cells. The antibody
as only reactive toward the human NIPA protein and
id not detect the murine homolog in NIH 3T3 cells.
hen applied to indirect immunofluorescence in HeLa
ells, the NIPA antiserum detected NIPA exclusively in
he nucleus (Figure 1E). As observed with overex-
ressed NIPA (Figure 1A), endogenous NIPA became
bundant in S phase and was phosphorylated at G2/M
Figure 1F).
IPA Is a Human F-Box Protein
hat Associates with Skp1
e next performed a yeast two-hybrid screen using the
ull-length NIPA protein as bait to screen a human testis
DNA library for additional NIPA binding proteins. Sur-
risingly, all specific clones identified from this screen
ncoded human Skp1 (data not shown). To confirm this
ssociation, we tested the ability of a recombinant GST-
kp1 fusion protein to interact with NIPA wild-type (wt)
tably expressed in NIH 3T3 cells (Figure 2A).
Since many proteins known to associate with Skp1
re F-box proteins, we searched for an F-box motif in
he NIPA sequence. Close examination of this sequence
evealed an F-box motif in the N terminus of the NIPA
rotein (amino acids 170–210) (Figure 2B). Mutation of
he core LP residues (L170 and P171) of the NIPA F-box
bolished binding to Skp1, thus identifying this motif as
he relevant binding region and suggesting that NIPA is
human F-box-containing protein (Figure 2A). Addi-
ionally, we identified binding determinants for NIPA in
oth the N and C termini of Skp1, which is thought to
e typical for the Skp1-F-box interaction (data not
hown) (Ng et al., 1998).
IPA Is Part of a Functionally Active SCF Complex
hat Assembles in a Cell-Cycle-Regulated Manner
ince we confirmed that NIPA interacts with Skp1 and
hat this interaction requires a functional F-box motif,
e examined whether NIPA assembles with the other
nown mammalian SCF subunits (Cul1, Roc1) to form
n SCF complex. To test for in vivo complex formation,
e precipitated Flag-NIPA from 293T cell lysates trans-
ected with the constructs indicated (Figure 3A). As de-
icted in this figure, NIPA copurified with Skp1, Cul1,
nd Roc1 to form a complete SCF complex. Complex
ormation was also found to occur in vitro using a cell-
ree system, thus suggesting direct interaction (Fig-
re 3B).
Having shown that NIPA can form an SCF complex
SCFNIPA), we next determined whether SCFNIPA pos-
esses associated ubiquitination-promoting activity. As
hown in Figure 3C, increased ubiquitination-promoting
ctivity was observed after preincubation of GST-NIPA
ith extracts derived from cells transfected with the
CF core components Skp1, Cul1, and Roc1 (+SCF)
Figure 3C, compare lanes 3 and 4). When preincubated
ith untransfected extracts (−SCF) (lane 7) or not prein-
ubated (lane 2), GST-NIPA exhibited only background
ctivity, similar to GST alone (lane 1). These findings
uggest that SCFNIPA contains ubiquitin ligase activity
nd interacts with the ubiquitination machinery.
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(A) Analysis of NIPA at different stages of the cell cycle. (Left) Cycling cultures of an NIH 3T3 cell line expressing Flag-NIPA wt were arrested
in G0/1, S, or G2/M or left untreated. Thereafter, cell lysates were prepared and processed for Western blotting with the antibodies indicated
(IB, immunoblot). (Right) Cell cycle distribution of the cells shown in the left panel.
(B) Cells, unsynchronized (Ø) or synchronized at G2/M, were lysed and the lysates treated with potato acid phosphatase for 10 min or left
untreated as indicated.
(C) NIH 3T3 cells described in (A) were released from blocks in S phase (left panel) or at G2/M (right panel), sampled at the given intervals,
and processed for Western blotting.
(D) COS1 cells were transiently transfected with Flag-NIPA wt or Flag-NIPA S354A, enriched at G2/M, or left unsynchronized, then collected
for Western blotting.
(E) Characterization of a NIPA-specific antiserum. NIH 3T3 lysate (lane 1), NIH 3T3 lysate from cells transfected with human NIPA (lane 2),
and HeLa lysate (lane 3) were resolved by SDS-PAGE and immunoblotted with an affinity-purified polyclonal murine NIPA antiserum. (Right)
HeLa cells were subjected to indirect immunofluorescence using NIPA antiserum. DAPI and β-tubulin stains visualize the nucleus and cyto-
plasm, respectively.
(F) Analysis of endogenous NIPA at different stages of the cell cycle. HeLa cells were arrested in G0/1, S, or G2/M or left untreated, lysed, and
processed for Western blotting with the NIPA antiserum described in (E).We reasoned that the cell-cycle-dependent phos-
phorylation of NIPA from G2 phase through mitosis (see
Figure 1) might regulate its interaction with Skp1 and
thus to the SCF core. To address this issue, we com-
pared the binding of GST-Skp1 to NIPA expressed in
either unsynchronized or G2/M cells. Strong retention
of NIPA with GST-Skp1 was observed only in unsyn-
chronized cells, with no binding detected in G2/M cells
(Figure 3D). To verify these data in vivo, we precipitated
endogenous NIPA from either interphase or G2/M HeLa
cells and assayed for binding to endogenous Skp1.
Again, binding of NIPA to Skp1 was only observed ininterphase cells and was not detectable in G2/M cells
(Figure 3E). Thus, cell-cycle-dependent phosphoryla-
tion of NIPA can regulate its binding to Skp1, and this
posttranslational modification likely functions as a tim-
ing switch for the disassembly of the SCFNIPA complex.
Accordingly, a functional SCFNIPA complex would only
occur in the cell cycle segment from G1 to G2 phase.
Identification of Nuclear Cyclin B1 as an
Ubiquitination Target of the SCFNIPA Complex
Cyclin B1 levels oscillate during the cell cycle, with
increasing levels as S and G phases progress and a2
Cell
48Figure 2. NIPA Is a Human F-Box Protein that Associates with Skp1
(A) NIPA interacts with Skp1 via the F box. Flag-NIPA wt and Flag-NIPA FM (F-box mutant) were expressed in 293T cells. Lysates were
incubated with GST or GST-Skp1 protein, and the bound proteins were detected by Western blotting as indicated.
(B) CLUSTAL W alignments of F-box motifs comparing NIPA (aa 170–210) with known human F-box proteins. Identical residues (dark gray),
similar residues (light gray), conservative residue differences (:).peak at G2/M. Cyclin B1 is largely cytoplasmic during p
ninterphase, and nuclear accumulation of phosphory-
lated cyclin B1 is mainly restricted to G2/M (Hagting et n
ual., 1999). As illustrated in Figure 4A, NIPA is phosphor-
ylated and hence dissociated from the SCF core in no- u
lcodazole-arrested prometaphase cells, in which cyclin
B1 strongly accumulates. Furthermore, we observed
unuclear cyclin B1 levels in interphase cells to increase
upon inhibition of the proteasome (Figure 4B). Thus, we o
ginvestigated whether NIPA can interact with cyclin B1.
We precipitated cyclin B1 from either interphase cells t
aor nocodazole-arrested G2/M cells and assayed for co-
precipitated NIPA. Figure 4C demonstrates the binding 5
mof cyclin B1 to NIPA only in interphase cells, while no
binding was seen in G2/M cells. Thus, binding of NIPA (
Sto cyclin B1 only occurs when the SCFNIPA complex is
assembled, and disassembly of the SCFNIPA complex i
Svia phosphorylation of NIPA abrogates the ability of
NIPA to bind cyclin B1. i
pGiven these observations, we sought to determine
whether the SCFNIPA complex can ubiquitinate cyclin p
fB1. For this purpose, we established a reconstituted
SCF system using proteins from baculovirus-infected a
ISf21 cells. Purified SCFNIPA, SCFCdc4 as a control SCF
complex (Strohmaier et al., 2001), or SCF core complex s
d(SCF(ØF-box) = Skp1, Cul1, Roc1) were assembled and
incubated with GST-cyclin B1 as substrate. Before- d
hand, GST-cyclin B1 was preincubated with HeLa cell
lysates. In this system, only the SCFNIPA complex was c
aable to efficiently ubiquitinate cyclin B1 (Figure 4D, up-er panel, lane 2). Neither the SCF core complex alone
or the SCFCdc4 complex showed significant ubiquiti-
ation activity toward cyclin B1 (lanes 3 and 4). Anti-
biquitin Western blotting demonstrated efficient ubiq-
itination mediated by the SCFNIPA complex (Figure 4D,
ower panel).
We next carried out an in vitro ubiquitination assay
sing HeLa extracts that were either NIPA inactivated
r reconstituted with purified protein to further investi-
ate the requirement of NIPA for cyclin B1 ubiquitina-
ion. NIPA inactivation was performed using an siRNA
pproach (Figure 4E) described in detail below (Figure
A). As shown in Figure 4F, NIPA inactivation caused a
arked reduction of cyclin B1 ubiquitin ligation activity
lane 3). In contrast, upon reconstitution with purified
kp1-NIPA complex, ubiquitination of cyclin B1 was re-
nforced (Figure 4F, lane 5). Addition of purified Skp1-
kp2 complex was not able to restore cyclin B1 ubiquit-
nation (lane 6). Of note, cyclin B1 was upshifted when
reincubated; this alteration most likely represents
hosphorylation of the protein and presumably con-
orms to the modification required for SCFNIPA-medi-
ted ubiquitination (Figure 4D, upper panel; Figure 4F).
mportantly, the addition of purified Skp1-NIPA not only
timulated ubiquitination of cyclin B1 but markedly in-
uced cyclin B1 degradation as measured by a degra-
ation assay (Figure 4G).
We then tested for in vivo ubiquitination of nuclear
yclin B1 by SCFNIPA. Because phosphorylation of NIPA
t G /M should inactivate the SCFNIPA complex, we2
A Role for NIPA at the G2/M Transition
49Figure 3. NIPA Defines a Functionally Active SCF Complex that Assembles in a Cell-Cycle-Regulated Manner
(A) NIPA interacts with SCF components in vivo. Xpress-Skp1, Myc-Cul1, and HA-Roc1 were cotransfected with or without Flag-NIPA in 293T
cells and interactions determined by anti-Flag immunoprecipitation.
(B) NIPA interacts with SCF components in vitro. A glutathione-agarose precipitation assay using GST-NIPA wt or GST as control was
performed to assess binding to in vitro-translated and 35S-labeled Skp1 and Cul1.
(C) The SCFNIPA possesses ubiquitination-promoting activity in vitro. Glutathione-agarose beads preloaded with GST or GST-NIPA and either
preincubated in lysates of 293T cells transfected with Skp1, Cul1, and Roc1 (+SCF) (lanes 3–6) or in lysates of untransfected 293T (−SCF)
(lane 7), or not preincubated (lanes 1 and 2), were processed for their ability to promote an in vitro ubiquitination reaction.
(D) NIPA associates with Skp1 in interphase only. GST-Skp1 or GST was incubated with lysates collected from unsynchronized or G2/M-
synchronized NIH 3T3 cells expressing Flag-NIPA wt, and binding was determined.
(E) In vivo binding of NIPA to Skp1 is restricted to interphase. Extracts of unsynchronized or G2/M-synchronized HeLa cells were immunopreci-
pitated with purified NIPA antibody or with control IgG fractions. Immunoprecipitates and lysates were immunoblotted with either Skp1 or
NIPA antibodies.compared interphase cells with nocodazole-arrested
G2/M cells. The phosphorylation-deficient NIPA S354A
mutant, which should assemble a constitutively active
SCFNIPA-S354A complex, was included in the assay.
Cyclin B1 was immunoprecipitated from nuclear cell
extracts expressing the plasmids indicated in Figure
4H. In interphase cells, expression of both NIPA wt and
NIPA S354A stimulated ubiquitination of cyclin B1 (Fig-
ure 4H, lanes 2 and 3). However, when cyclin B1 precip-
itated from G2/M cells was examined, ubiquitination of
the cyclin protein was observed only in the NIPA S354A
sample (lanes 6 and 7). Notably, essentially no ubiquiti-
nation of cyclin B1 was observed when the cyclin B1
protein precipitated from the corresponding cytoplas-
mic cell extracts was examined (data not shown). Thus,
nuclear cyclin B1 is targeted for ubiquitination by the
SCFNIPA complex in interphase only, whereas the
SCFNIPA-S354A complex remains constitutively active
and targets nuclear cyclin B1 throughout G /M.2NIPA Silencing Stabilizes Nuclear Cyclin B1
and Induces Premature Mitotic Entry
We used an siRNA knockdown approach to further as-
sess the role of SCFNIPA in controlling the nuclear abun-
dance of cyclin B1. On both the RNA and protein levels,
a significant reduction of NIPA expression was ob-
served upon NIPA siRNA treatment (Figure 5A). Silenc-
ing of NIPA caused a considerable accumulation of
cyclin B1 protein in nuclear extracts as compared to
cells transfected with control siRNA (Figure 5A, right
panel), whereas, on the RNA level, cyclin B1 was not
affected (Figure 5A, left panel). We then tested the ef-
fect of silencing NIPA expression in HeLa cells arrested
in S phase. Cells were synchronized by thymidine treat-
ment, and pulse-chase analysis was performed. Nuclear
cyclin B1 was degraded in cells transfected with con-
trol siRNA, whereas the levels of nuclear cyclin B1 re-
mained constant in cells treated with NIPA siRNA (Fig-
ure 5B).
Cell
50Figure 4. Identification of Nuclear Cyclin B1 as a Ubiquitination Target of the SCFNIPA Complex
(A) Phosphorylation of NIPA correlates with cyclin B1 accumulation. HeLa cells were arrested at prometaphase using nocodazole or left
untreated, then processed for Western blotting with anti-NIPA and anti-cyclin B1 antibodies.
(B) Proteasome-dependent degradation of nuclear cyclin B1 in interphase. HeLa cells were either left untreated or treated with the proteasome
inhibitors (PI) LLnL and MG132 for 3 hr before nuclear extract preparation and Western blotting using a cyclin B1 antibody. The purity of the
cell fractions was assessed using α-tubulin and lamin A as cytoplasmic or nuclear markers, respectively.
(C) Cell-cycle-dependent interaction of NIPA and cyclin B1 in vivo. NIH 3T3 cells expressing NIPA were either left untreated or synchronized
at G2/M. Normalized amounts of lysate were processed for cyclin B1 immunoprecipitation. A nonspecific rabbit antiserum was used as
a control.
(D) In vitro ubiquitination of cyclin B1 using a purified SCF system. SCFNIPA, SCFCdc4, or SCF core complex (SCFØF-box = Skp1, Cul1, Roc1)
were expressed with baculoviruses and purified from Sf21 cells. The insect cell-derived GST-cyclin B1 substrate was preincubated in HeLa
lysate prior to the reactions. Samples were supplemented with ubiquitin, E1, E2 (Cdc34), and an ATP regeneration system.
(E) Western blot analysis of cells used in (F) and (G) with polyclonal NIPA antiserum.
(F) In vitro ubiquitination of cyclin B1 using reconstituted HeLa extracts. GST-cyclin B1 was incubated with extracts derived from HeLa cells
treated with either control or NIPA siRNAs as described below. Recombinant insect cell-derived Skp1-NIPA or Skp1-Skp2 complexes were
added as indicated.
(G) NIPA promotes destruction of cyclin B1 in vitro. Purified GST-cyclin B1 was incubated with extracts derived from HeLa cells treated with
NIPA siRNA, and baculovirus-derived Skp1-NIPA or Skp1-Skp2 complexes were added, as indicated. The degradation reaction was performed
under conditions that conserve proteasomal activity.
(H) SCFNIPA ubiquitinates nuclear cyclin B1 in a cell-cycle-regulated manner in vivo. Expression plasmids encoding NIPA wt or NIPA S354A,
or empty vector were each cotransfected with pCMV-HA-ubiquitin in COS1 cells. The cells were then either synchronized at G2/M (lanes
5–8) or left unsynchronized (lanes 1–4). Following treatment with LLnL, nuclear extracts were prepared and subjected to cyclin B1 immuno-
precipitation.
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51We reasoned that nuclear accumulation of cyclin B1
evoked by NIPA inactivation might affect the timing of
mitotic entry. First, we determined the effect of NIPA
inactivation on the cyclin B1/Cdk1 kinase activity using
a histone H1 kinase assay. As depicted in Figure 5C,
cyclin B1-associated kinase activity in cells released
from G1/S peaked significantly earlier in NIPA knock-
down cells (5 hr) as compared to control cells (10 hr).
Furthermore, kinase activity in NIPA knockdown cells
remained at high levels throughout the period under
observation. Next, we examined the kinetics of mitotic
entry in cells released from G1/S using phosphorylation
of histone H3 as a mitotic marker. Premature mitotic
entry was clearly observed in NIPA knockdown cells,
while control cells displayed a physiological course of
mitotic entry (Figure 5D). Of note, NIPA knockdown
cells remained in mitosis longer than the corresponding
control cells (Figure 5D). Western blot analysis of cells
used in Figures 5C and 5D demonstrated efficient re-
duction of NIPA (Figure 5E).
We proceeded next to examine the cell cycle distri-
bution of NIPA-inactivated cells. As shown in the 2D
cell cycle analysis in Figure 5F, left panel, silencing of
NIPA caused an increase of cells with a 4N DNA
content. This finding likely reflects the prolonged mito-
sis observed in Figure 5D. We evaluated the specific
mitotic forms of the 4N cells by indirect immunofluores-
cence. As shown in Figure 5F, middle and right panels,
the majority of mitotic cells treated with NIPA siRNA
were found to be arrested in prometaphase (charac-
terized by spindle morphology and phospho-histone
H3 pattern). While premature mitotic entry in NIPA
knockdown cells is likely to be a consequence of ele-
vated nuclear cyclin B1 levels, the mitotic block at pro-
metaphase is presumably not cyclin B1-related. The
observed prometaphase arrest may represent a com-
pound phenotype resulting from the accumulation of
multiple NIPA substrates. Alternatively, this mitotic ar-
rest might occur due to activation of a mitotic check-
point caused by the premature mitotic entry.
A Phosphorylation-Deficient NIPA Mutant, NIPA
S354A, Retains Activity toward Cyclin B1
at G2/M and Delays Mitotic Entry
If the SCFNIPA complex normally dissociates as the cell
cycle progresses toward G2/M to allow for expression
of cyclin B1, then expression of the phosphorylation-
deficient mutant NIPA S354A, which forms a constitu-
tively active SCFNIPA-S354A complex, would be predicted
to block cyclin B1 accumulation and delay mitotic en-
try. We performed pulse-chase analysis of NIH 3T3 cells
expressing either NIPA wt or NIPA S354A to evaluate
nuclear cyclin B1 turnover at G2/M. As shown in Figure
6A, turnover of cyclin B1 in nocodazole-arrested cells
was only observed in cells expressing the NIPA S354A
mutant. Thus, the NIPAS354A complex retains activity to-
ward cyclin B1 at G2/M.
To investigate the impact of the NIPA S354A mutant
on mitotic entry, we generated cell lines with inducible
expression of either NIPA wt or NIPA S354A (Figure 6B,
left panel). Cells were arrested at G1/S 24 hr postinduc-
tion, and the block was subsequently removed to per-mit synchronized cell cycle progression. Using 2D cell
cycle analysis, an evident delay of mitotic entry was
observed in cells expressing the phosphorylation-defi-
cient NIPA S354A mutant as compared to NIPA wt- or
vector-containing cells (Figure 6C). To rule out that this
observation was the result of a proapoptotic effect of
NIPA S354A, we applied TUNEL analysis to the induc-
ible cell lines used and found no induction of apoptosis
in the respective cells (Figure 6B, right panel). Immuno-
fluorescence microscopy revealed that the apparent
delay of NIPA S354A cells occurred at an early stage of
mitotic entry (prophase), given that nuclear envelope
breakdown had not yet occurred (Figure 6D) and his-
tone H3 phosphorylation was not yet detectable (data
not shown).
To correlate the extent of delay at mitotic entry to the
expression level of NIPA S354A in terms of a dose-
effect relationship, we generated single cell-derived
NIH 3T3 clonal cell lines that stably express NIPA wt or
NIPA S354A at various levels (Figure 6E, upper panel).
As demonstrated by the 2D cell cycle analysis in Figure
6E, lower panel, expression of NIPA S354A resulted in
a concentration-dependent accumulation at G2/M. This
dose-effect relationship, which correlates with the cell
cycle effects observed in the inducible cell system (Fig-
ures 5C and 5D), argues against the possibility of clonal
variations among the respective cell lines. Thus, the
phosphorylation process involving NIPA at G2/M, which
times the dissociation of the SCFNIPA complex, appears
to be important for normal mitotic entry.
Discussion
Regulated protein ubiquitination and proteolysis are
prerequisites for the integrity of the cell cycle, and the
regulated activity of E3 ubiquitin ligases is central to
this process. The most prominent groups of these pro-
teins are the APC and SCF families of ubiquitin ligases.
While the APC ligases are mainly active after meta-
phase and in G1, SCF ligases target substrates for deg-
radation at the G1/S, S and G2 phases of the cell cycle.
In this study, we have identified NIPA as a human
F-box protein that defines an SCF-type E3 ligase
(SCFNIPA). One of the prominent features of this ubiq-
uitin ligase is that its activity oscillates throughout the
cell cycle, and cell-cycle-regulated phosphorylation of
NIPA constitutes the responsible timing circuit. We
identify nuclear cyclin B1 to be a critical substrate of
the SCFNIPA complex in interphase. According to the
oscillating activity of SCFNIPA, this targeting process is
terminated at G2/M to allow for nuclear cyclin B1 accu-
mulation, which is necessary for mitotic entry. Consis-
tent with these data, evasion of this oscillation using
the constitutively active SCFNIPA-S354A complex delays
mitotic entry. In contrast, inactivation of NIPA by
siRNAs results in nuclear accumulation of cyclin B1
during interphase, with the consequence of premature
mitotic entry. Given the well-characterized mitotic ubiq-
uitination of cyclin B1 by the APC, the identification of
an SCF complex that targets cyclin B1 during in-
terphase further defines an E3 ligase network that is
operative in mitotic control.
Cell
52Figure 5. NIPA Silencing Stabilizes Nuclear Cyclin B1 and Induces Premature Mitotic Entry
(A) Silencing of NIPA results in nuclear accumulation of cyclin B1. HeLa cells were transfected with either control siRNA or NIPA siRNA
oligonucleotides. Expression of NIPA and cyclin B1 RNAs was analyzed by quantitative PCR (left panel) or Northern blot analysis (middle
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53lated in order to interact with NIPA. In our experimentalregulation of this complex occurs at both the level of
panel). Protein expression in nuclear extracts was demonstrated using NIPA-antiserum and anti-cyclin B1 antibody. Immunoblots detecting
lamin A and α-tubulin were used to assess the quality of the extract fractionations (right panel).
(B) SCFNIPA degrades nuclear cyclin B1 in S phase. HeLa cells were treated with NIPA or control siRNAs and arrested in S phase. The extent
of cyclin B1 degradation was assayed using pulse-chase analysis.
(C) NIPA inactivation results in premature activation of cyclinB1/Cdk1 kinase activity. HeLa cells were transfected with either NIPA or control
siRNAs, synchronized at G1/S, and subsequently released. Thereafter, cells were harvested at the indicated time points and processed for
anti-cyclin B1 immunoprecipitation. Precipitates were subsequently applied to an in vitro histone H1 kinase assay.
(D) NIPA inactivation promotes premature mitotic entry. HeLa cells treated as in (C) were released from G1/S and fixed at the indicated time
points. Thereafter, cells were subjected to indirect immunofluorescence using phospho-histone H3 and α-tubulin antibodies, and DAPI stain-
ing as markers to distinguish mitotic cells. The graph represents the results from four independent experiments.
(E) Western blot analysis of cells used in (C) and (D) with polyclonal NIPA antiserum.
(F) NIPA inactivation causes a mitotic arrest in prometaphase. (Left) The cells described in (A) were processed for 2D cell cycle analysis.
(Middle and right) Cells described in (A) were stained with anti-α-tubulin- (red), anti-histone-H3(S10-P)- (green), and DAPI (blue), then visual-
ized by fluorescence microscopy. The fraction of cells with 4N DNA content was quantified with regard to the different stages of mitosis.SCFNIPA Functions as a Phosphorylation-Dependent
Cell Cycle Oscillator
Protein degradation acts as a key trigger at various
points of the cell cycle to control cell cycle transitions.
Thus, mechanisms that precisely regulate the timing of
this process must exist. SCF-mediated proteolysis is
largely determined by the F-box component, which de-
fines the substrate binding specificity of a respective
SCF complex. The equilibrium between different F-box
proteins and the limited amount of SCF core complexes
is poorly understood but thought at least in part to be
a matter of timely proteolysis of the F-box subunits by
a mechanism involving autoubiquitination (Galan and
Peter, 1999; Zhou and Howley, 1998). Furthermore,
APC-dependent degradation has been reported for the
F-box proteins Tome-1 and Skp2 (Ayad et al., 2003;
Bashir et al., 2004; Wei et al., 2004).
In this report, we show that cell-cycle-dependent
phosphorylation of an F-box protein, NIPA, acts as a
timing circuit for the activity of its corresponding SCF
complex. This mechanism may represent a more gen-
eral principle to regulate SCF activity. Subsequent to
the NIPA phosphorylation event at G2/M, we observed
expression levels of NIPA to decline as cells exited mi-
tosis and entered G1. Therefore, phosphorylated NIPA
may be a substrate for proteosomal degradation itself.
While we have not identified the serine/threonine ki-
nase(s) responsible for NIPA phosphorylation as yet, it
is intriguing to speculate that such a kinase could be
stimulated apart from its physiologic cell-cycle-depen-
dent activation by oncogenic tyrosine kinases as well.
As previously reported, we cloned NIPA in complex with
the oncogenic tyrosine kinase NPM-ALK and deter-
mined coexpression of activated ALK fusions to be as-
sociated with NIPA serine phosphorylation (Ouyang et
al., 2003). In addition, we have observed NIPA serine
phosphorylation when overexpressing in cells an acti-
vated form of the Abl tyrosine kinase v-Abl (F.B. and
J.D., unpublished data). Such a mechanism could un-
ravel a process by which these oncoproteins and per-
haps other tumor-associated kinases interfere with cell-
cycle-dependent proteolysis and faciliate inappropriate
mitotic entry.
Cyclin B1 Is a Substrate of the SCFNIPA Complex
during Interphase
Cyclin B1/Cdk1 (MPF) controls mitotic entry, and theenzymatic activity and subcellular distribution. Spatial
control of cyclin B1 is a critical determinant of MPF
activity because cyclin B1 can exert its ability to pro-
mote mitotic entry only when located within the nu-
cleus. In addition to its role in promoting M phase, a
recent report further revealed a function for cyclin B1
in supporting DNA replication when trapped to the nu-
cleus (Moore et al., 2003). Thus, regulatory means for
timing the nuclear translocation of cyclin B1 are vital to
ensure the fidelity of S phase progression and mitotic
entry. To date, the predominantly cytoplasmic localiza-
tion of cyclin B1 in interphase, which is reversed only
upon phosphorylation of the CRS region at G2/M, and
the switchlike upregulation of Cdk1-cyclin B1 activity
to increases in cyclin B1 concentration have emerged
as potential regulatory restraints (Pines and Hunter,
1991; Yang et al., 1998). These data identify a further
mechanism explaining how the cell is protected from
premature nuclear accumulation of cyclin B1 and, thus,
premature mitotic entry: proteolytic degradation during
interphase based on SCF-mediated ubiquitination. Pre-
viously, ubiquitination as a means of cyclin B1 regula-
tion had been demonstrated only in mitosis, mediated
by the APC ubiquitin ligase (Zachariae and Nasmyth,
1999). Our data suggest a dual mode of degradation for
cyclin B1 involving the SCFNIPA complex during in-
terphase in addition to the known APC activity in mito-
sis. Cooperation and interdependent activity of the APC
and SCF E3 ubiquitin ligases may be a more general
oscillation mechanism in the control of cell-cycle-
dependent protein abundance. In this regard, a recent
report has described a similar mechanism involving the
APC and SCF for ubiquitin-mediated degradation of
human Cdc25a (Busino et al., 2003). In fission yeast,
a dual mechanism of cell-cycle-regulated destruction
involving both the APC/C and the SCFPop1/Pop2 com-
plexes has been described for Cig2, a B-type cyclin
active in S phase of the cell cycle (Yamano et al., 2000).
Together, these data support our model of a dual mode
of degradation for cyclin B1 in mammalian cells. The
formal possibility exists that ubiquitination of cyclin B1
in interphase is mediated also in part by the APC. How-
ever, this mechanism seems rather unlikely, given a re-
cent finding that restricts the interaction of the APC and
cyclin B1 to mitosis (Yamano et al., 2004).
Since most known SCF substrates are phosphory-
lated prior to interaction with their respective F-box
proteins, it is likely that cyclin B1 must be phosphory-
Cell
54Figure 6. A Phosphorylation-Deficient NIPA Mutant, NIPA S354A, Retains Activity toward Cyclin B1 at G2/M and Delays Mitotic Entry
(A) NIPA S354A degrades nuclear cyclin B1 at G2/M. NIH 3T3 cells transfected with either NIPA wt or NIPA S354A were synchronized at
G2/M and subsequently pulsed with 35S-methionine and cysteine. The extent of cyclin B1 degradation is shown in an autoradiogram of
immunoprecipitated endogenous cyclin B1.
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(B) Generation of inducible cell lines expressing NIPA wt and NIPA S354A. (Left) Immunoblot showing expression in either uninduced or
induced cells. (Right) TUNEL analysis of NIPA wt- (green), NIPA S354A- (blue), or empty vector-containing cells (green).
(C) Induced expression of the phosphorylation-deficient mutant NIPA S354A delays mitotic entry. Cell lines described in (B) were synchronized
at G1/S 24 hr postinduction. Cells were released from the block and their cell cycle distribution was measured at the indicated time points.
(D) NIPA S354A delays mitotic entry at prophase. Cells treated as in (C) were stained with anti-α-tubulin antibody (red) and DAPI (blue) and
visualized by fluorescence microscopy at the 10 hr time point.
(E) NIPA S354A influences mitotic entry in a dose-effect-related manner. Stably transfected NIH 3T3 clones expressing NIPA wt, NIPA S354A,
or empty vector were analyzed by 2D cell cycle analysis.Figure 7. Model of SCFNIPA Activity during the Cell Cycle
Phosphorylation of NIPA governs the ubiquitination activity of the SCFNIPA complex, thereby allowing nuclear cyclin B1 levels to increase as
cells progress toward G2/M.setting, in vitro ubiquitination of cyclin B1 using a re-
constituted SCF system was only observed with puri-
fied cyclin B1 preincubated with cell lysates before-
hand (Figure 4D). It is probably the case that this
preincubation process involves phosphorylation of cyclin
B1, which may represent a prerequisite for cyclin B1
degradation by the SCFNIPA. We demonstrate that inac-
tivation of NIPA using siRNA causes nuclear cyclin B1
to accumulate in interphase. This untimely accumula-
tion associates with premature cyclin B1/Cdk1 activity
and early mitotic entry. Recent studies demonstrate
that nuclear localization is a prerequisite for cyclin B1
to be active, and premature localization of cyclin B1 to
the nucleus induces DNA replication and evokes mi-
totic entry (Li et al., 1997; Moore et al., 2003). Thus,
NIPA knockdown cells exhibit a phenotype with regard
to their kinetics of mitotic entry that seems concordant
with the ubiquitination activity of NIPA toward nuclear
cyclin B1 during interphase. In contrast, the arrest in
prometaphase we observed in NIPA knockdown cellsthis observation may represent a compound phenotype
resulting from the accumulation of multiple yet-to-be-
identified NIPA substrates. A further conceivable cause
could be a mitotic checkpoint activated by premature
mitotic entry.
In summary, our results suggest a role for the SCFNIPA
complex in timing mitotic entry. The underlying mecha-
nism is based on the oscillating activity of the SCFNIPA,
which promotes degradation of nuclear cyclin B1 dur-
ing interphase but allows for the accumulation of cyclin
B1 through S and G2 phases to trigger the G2-to-M tran-
sition (Figure 7). Our data thus define a cellular mecha-
nism that times the nuclear accumulation of cyclin B1
with mitotic entry.
Experimental Procedures
Plasmids and Antibodies
Details of the construction of plasmids pcDNA3.1-Flag-NIPA wt,
-NIPA S354A, and -NIPA FM (F-box mutant) are available from the
authors upon request. Point mutations of the NIPA cDNA were en-
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56(Stratagene), while deletion mutants were prepared by PCR using s
Sstandard cloning procedures. Mouse monoclonal antibodies were
purchased from Sigma (anti-Flag [M2], anti-Myc [clone 9E10], anti- p
fβ-actin), Qiagen (anti-[His]6), Invitrogen (anti-Xpress), and Santa
Cruz (anti-α-tubulin, anti-lamin A). Polyclonal rabbit antibodies were
from Santa Cruz (anti-HA tag [Y11], anti-cyclin A, anti-cyclin B1, anti-
Uubiquitin), Zymed (anti-Skp1), and Upstate (anti-phospho-H3).
S
TAntibody Preparation
sBacterially produced GST-NIPA (BL-21 cells) was used to raise
opolyclonal antibodies in mice (Davids Biotechnology, Regensburg,
BGermany). The resulting serum was affinity purified.
b
MYeast Two-Hybrid System
tThe full-length NIPA cDNA was cloned into the yeast expression
pvector pBTM116 for use as the bait to screen a human testis library
t(Clontech) (9 × 106 clones) in the Saccharomyces cerevisiae L40
(strain, as previously described (Bai et al., 2002).
c
1Cell Culture, Cell Cycle Synchronization, and Transfection
NIH 3T3, HeLa, COS1, and 293T cells were cultivated in DMEM
containing 10% FCS. Transient transfections of COS1 and 293T P
cells were performed using the DOTAP (Roche) and Lipofectamine T
2000 (Invitrogen) transfection reagents. Stable transfections of NIH F
3T3 cells have been described before (Bassermann et al., 2002). n
For inducible expression, the GeneSwitch expression system (Invi- i
trogen) was used. Cells were treated with 2 mM thymidine or 70 w
M quercetin for 16 hr at 37°C to arrest them in S phase or were n
arrested at G2/M by sequential culture with 2 mM thymidine and
500 ng/ml nocodazole. For synchronization in G0/1, cells were se-
rum starved for 48 hr (0.5% FCS). Synchronization at G1/S was I
performed using a double thymidine block. T
u
Cell Cycle Analysis p
For BrdU incorporation and DNA content analysis, cells were f
pulsed with 10 M BrdU (BD Biosciences) for 40 min and subse- S
quently stained according to a standard protocol. One- and two- c
dimensional flow cytometry was performed to detect either PI or
both fluorescein and PI. To quantify cell cycle distribution, the n
FlowJo software (Tree Star Inc., Stamford, Connecticut) was uti- d
lized. C
siRNA
HsiRNAs were purchased from Proligo and transfected into subcon-
Cfluent HeLa cells using Lipofectamine 2000 (Invitrogen) according
ato the manufacturer’s instructions. The target sequence of NIPA
asiRNA was 5#-GTCCACGTCACTGCCTGTA-3#. A firefly luciferase
HsiRNA served as the control.
s
Immunoprecipitation, Western Blotting,
and Phosphatase Assays I
Immunoprecipitations were performed as described (Duyster et al., S
1995). Phosphoprotein digestion was carried out in a volume of 50 e
l in phosphatase buffer (40 mM PIPES [pH 6.0], 1 mM DTT, 1 mM t
MnCl2, 100 g/ml BSA, 50 M leupeptin) using potato acid phos- s
phatase, type III (Sigma) at 100 g/ml.
Northern Blotting and Quantitative PCR
Total RNA was extracted from HeLa cells using Trizol reagent (Invi- A
trogen). Hybridization was performed with a 32P-labeled human
NIPA probe obtained by Hind III digestion of the full-length NIPA W
cDNA. Quantitative PCR was performed with GAPDH-, NIPA-, and r
cyclin B1-specific primers using standard procedures. W
C
GST Fusion Proteins and Pull-Down Assays k
NIPA wt, NIPA FM, and Skp1 were expressed in E. coli using pGEX c
vectors (Amersham). GST pull-down assays were performed as w
previously described (Bassermann et al., 2002). t
t
IInsect Cell-Derived Recombinant Proteins
Complementary DNAs encoding human NIPA and Cdc4 were in- C
Sserted into the pBacPak-9 vector (Clontech). Baculoviruses ex-
pressing human GST-Skp1, HA-Cul1, Roc1, and Skp2 were kindly supplied by M. Pagano. All recombinant proteins were produced in
f21 insect cells. The different complexes were formed by coex-
ression of the respective baculoviruses and purification per-
ormed using the GST and HA tags of Skp1 and Cul1, respectively.
biquitination of Cyclin B1 Using a Reconstituted
CF System
o assay in vitro ubiquitination of cyclin B1 using a reconstituted
ystem, purified GST-cyclin B1 (Upstate) was collected on glutathi-
ne-agarose beads and preincubated with HeLa lysate. GST-cyclin
1 was subsequently precipitated and washed three times in lysis
uffer and ubiquitination buffer (40 mM Tris-HCl [pH 7.6], 5 mM
gCl2, 1 mM DTT, 10% glycerol). Thereafter, GST-cyclin B1 was
ransferred to the ubiquitination reactions, which contained ap-
roximately 500 ng each of purified Skp1-NIPA or Skp1-Cdc4
ogether with Cul1-Roc1 complexes, 0.5 g/µl ubiquitin, 1 g E1
Affinity, Inc.), 1.3 g CDC34 (A.G. Scientific, Inc.), 10 mM phospho-
reatine, 100 g/ml creatine phosphokinase, 0.5 mM ATP, and
M ubiquitin aldehyde.
rotein Extraction for In Vitro Ubiquitination Assays
o generate cell extracts used for the experiments illustrated in
igure 4E, logarithmically growing HeLa cells were transferred to a
itrogen disruption bomb (Parr Instrument Company) and pressur-
zed at 70 bar for 30 min. Following decrompession, the material
as centrifuged at 10,000 × g for 10 min to obtain the S10 super-
atant.
n Vitro Ubiquitination and Degradation Assay
he ubiquitination reaction mix contained 0.5 g/µl ubiquitin, 1 M
biquitin aldehyde, 10 mM phosphocreatine, 100 g/ml creatine
hosphokinase, 0.5 mM ATP, 20 g HeLa extract, and 100 ng puri-
ied GST-cyclin B1 in ubiquitination buffer. Baculovirus-produced
kp1-NIPA or Skp1-Skp2 was added in similar amounts, as indi-
ated.
The cyclin B1 degradation assay was performed in a similar man-
er, except that proteasome inhibitors, ubiquitin, and ubiquitin al-
ehyde were omitted and extracts were prepared as described in
arrano et al. [1999].
istone H1 Kinase Assay
yclin B1 was immunoprecipitated from cell lysates as indicated
bove using anti-cyclin B1 (Santa Cruz). Precipitates were washed
nd transferred to the kinase reaction, which contained 80 mM
EPES (pH 7.4), 10 mM MgCl2, 50 M ATP, 1 Ci [γ-32P] ATP (Amer-
ham), 1 mM DTT, and 1 g histone H1.
mmunofluorescence Microscopy
taining procedures were performed essentially as described (Bai
t al., 2002). Primary antibodies (anti-NIPA, anti-α-tubulin, anti-his-
one H3[S10-P]) were used at dilutions of 1:1000, 1:400, and 1:200, re-
pectively.
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